Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
Evgen Pharma ( (GB:TCF) ) just unveiled an update.
Theracryf PLC, a UK-based company, has experienced a change in the breakdown of its voting rights. Octopus Investments Limited, based in London, England, has reduced its voting rights in Theracryf from 4.3% to 1.03%, as of March 11, 2025. This change was officially notified on March 12, 2025, indicating a significant shift in shareholder influence within the company.
More about Evgen Pharma
YTD Price Performance: -56.73%
Average Trading Volume: 1,887,416
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: £4.79M
For detailed information about TCF stock, go to TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue